Global Chronic Low Back Pain Treatment Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Chronic Low Back Pain Treatment Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Low back pain (LBP) is defined as a musculoskeletal pain, muscle tension, or stiffness localized below the bottom edge of the rib cage and above the gluteal sulcus, with or without sciatica, and is defined as chronic when it persists for 12 weeks or more.

Market Overview:

The latest research study on the global Chronic Low Back Pain Treatment market finds that the global Chronic Low Back Pain Treatment market reached a value of USD 5842.51 million in 2022. It’s expected that the market will achieve USD 7765.2 million by 2028, exhibiting a CAGR of 4.86% during the forecast period.

Inactive lifestyle is expected to drive the growth of the market

Bad living habits are increasingly appearing in people's lives, staying up late, sedentary, and not exercising. This phenomenon is particularly prominent in young people. Many people are in a sub-health state, and the prevalence of chronic low back pain The sharp increase has made the market for chronic low back pain continue to expand.

Development of new drugs and new treatments

As the demand continues to grow, the market for chronic low back pain treatment is fiercely competitive, new drug research and development is also accelerating, and new non-drug treatments are also popularizing and developing, which will help the market expand.The development and improvement of pain infusion pumps, non-opioid pain treatment methods, interventional pain management, physical therapy, psychotherapy, and pain rehabilitation have been improved, and more and more patients are inclined to these treatment methods.

Adverse drug reactions

Drugs used for the treatment of chronic low back pain have certain side effects, especially when taken for a long time, and chronic low back pain always needs to be taken. Therefore, the risk of taking drugs is very high, which may cause addiction, weakness, weakness, gastrointestinal upset, etc. . This will limit the development of the chronic low back pain treatment market to a certain extent.

The prevalence of chronic low back pain is increasing exponentially

Due to poor living habits, work reasons, and an increase in the elderly population, the prevalence of chronic low back pain is increasing worldwide, and the demand is increasing. The market for chronic low back pain treatment continues to grow.

Region Overview:

In global comparison, a significant portion of the revenue was generated in United States (32.5% in 2022).

Company Overview:

Pfizer is one of the major players operating in the Chronic Low Back Pain Treatment market, holding a share of 1.77% in 2023.

Pfizer

Pfizer Inc. is an American multinational pharmaceutical corporation headquartered in New York City. It is one of the world's largest pharmaceutical companies.

Novartis

Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales.

Segmentation Overview:

As for product types, the Nonsteroidal anti-inflammatory drugs segment held the largest market share in 2022.

Application Overview:

In the Chronic Low Back Pain Treatment market, 37.41% of the total value was generated through the Hospitals segment by application in 2022.

Key Companies in the global Chronic Low Back Pain Treatment market covered in Chapter 3:

Sanofi
Merck & Co., Inc.
Allergan
Mylan
Teva Pharmaceuticals
Eli Lilly and Company
Endo Pharmaceuticals Inc
Pfizer
Johnson & Johnson
Dr. Reddy’s Laboratories Ltd
Novartis
Takeda Pharmaceutical

In Chapter 4 and Chapter 14.2, on the basis of types, the Chronic Low Back Pain Treatment market from 2018 to 2029 is primarily split into:

Analgesic medications
Nonsteroidal anti-inflammatory drugs
Counter irritants
Antidepressants
Anticonvulsants

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Chronic Low Back Pain Treatment market from 2018 to 2029 covers:

Hospitals
Clinics
Ambulatory Surgical Centers
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)